Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
1(14%)
Results Posted
33%(1 trials)
Terminated
2(29%)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_2
2
29%
Ph phase_4
1
14%
Ph phase_3
2
29%

Phase Distribution

0

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
2(28.6%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

60.0%

3 of 5 finished

Non-Completion Rate

40.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(3)
Terminated(2)
Other(1)

Detailed Status

Completed3
Terminated2
unknown1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
1
Success Rate
60.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (28.6%)
Phase 32 (28.6%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

completed343%
unknown114%
terminated229%
recruiting114%

Recent Activity

1 active trials
Showing 5 of 7
completedphase_4

WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

NCT04990791
recruitingphase_3

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

NCT06591377
terminatednot_applicable

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

NCT04333407
completedphase_2

The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury

NCT01659307
completedphase_3

Ticagrelol Versus Aspirin in Ischemic Stroke

NCT03884530
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT04990791Phase 4

WILL lOWer Dose Aspirin be Better With Rivaroxaban in Patients With Chronic Coronary Syndromes?

Completed
NCT06591377Phase 3

Combining Aspirin With Ticagrelor or Cilostazol in Large-vessel Minor Stroke or TIA

Recruiting
NCT04333407Not Applicable

Preventing Cardiac Complication of COVID-19 Disease With Early Acute Coronary Syndrome Therapy: A Randomised Controlled Trial.

Terminated
NCT01659307Phase 2

The Effect of Aspirin on REducing iNflammation in Human in Vivo Model of Acute Lung Injury

Completed
NCT03884530Phase 3

Ticagrelol Versus Aspirin in Ischemic Stroke

Completed
NCT03583229Not Applicable

Coronary Artery Disease After Heart Transplantation

Unknown
NCT02326350Phase 2

ASpirin as a Treatment for ARDS (STAR): a Phase 2 Randomised Control Trial

Terminated

All 7 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
7